SUBSCRIBE
SUBSCRIBE

Genentech, Inc.

NEWS
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Genentech Ramps Up Partnerships for Next-Gen Cancer Drugs
August 13, 2015
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Genentech, AbbVie Confirm Venetoclax Met Primary Endpoint in Phase II Study
August 12, 2015
 · 
3 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Genentech’s Breakthrough Atezolizumab Joins Club of Successful Anti-PD-L1 Drugs, Shrinks Tumors in Bladder Cancer
July 13, 2015
 · 
3 min read
Business
The Power of Being a Genentech Alumni
July 1, 2015
 · 
1 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Drug Development
Genentech’s Ocrelizumab Wows in Late Stages and Eyes $18 Billion MS Market
June 30, 2015
 · 
4 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Almac Discovery Wrangles R&D Deal Worth $363.5 Million+ From Genentech
June 15, 2015
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
EXCLUSIVE: Genentech Enrolling Patients in Phase III Actemra Trial, Company Tells BioSpace
June 10, 2015
 · 
4 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Genentech Wins Breakthrough Nod From FDA for Systemic Sclerosis Treatment
June 10, 2015
 · 
4 min read
Biowarfare Company Emergent's Cancer Spinoff Aptevo Therapeutics to Employ 70 - 90 in Seattle
Business
Former Genentech CFO Launches Digital Lyra Health to Fix Mental Health System
June 5, 2015
 · 
3 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2023 Best Places to Work
  • 2024 Best Places to Work
JOBS
IN THE PRESS
Drug Development
Genentech’s Investigational Immunotherapy MPDL3280A Doubled The Likelihood Of Survival Compared With Chemotherapy In People With A Specific Type Of Lung Cancer
May 14, 2015
 · 
6 min read
Drug Development
Genentech’s Investigational Medicine Alectinib Shrank Tumors In Nearly Half Of People With Specific Type Of Lung Cancer
May 14, 2015
 · 
6 min read
Biotech Bay
BioSpace Temperature Poll: Will AbbVie, Genentech’s New Cancer Drug Be a Game Changer?
May 13, 2015
 · 
1 min read
Biotech Bay
Pivotal Data For Genentech Medicines In Lung And Blood Cancers To Be Presented At ASCO
May 11, 2015
 · 
1 min read
Pharm Country
Genentech’s Carol Wells Recipient Of The HBA’s Star Award
May 11, 2015
 · 
2 min read
Drug Development
AbbVie And Genentech Release: Investigational Medicine Venetoclax Receives Breakthrough Therapy Designation In Relapsed Or Refractory Chronic Lymphocytic Leukemia In Previously Treated Patients With The 17p Deletion Genetic Mutation
May 7, 2015
 · 
5 min read
Biotech Bay
Genentech Announces New STEM Education Initiative To Support South San Francisco Schools
May 4, 2015
 · 
4 min read
FDA
FDA Approves Genentech’s Drug To Treat Children’s Growth Disorder
March 24, 2015
 · 
4 min read
Business
Stand Up To Cancer Release: EHE International Joins Forces With Stand Up To Cancer And Genentech To Raise Awareness, Stress Importance Of Supporting Research
March 2, 2015
 · 
3 min read
Biotech Bay
Genentech Release: SNP Trace Panel Proves To Be A High-Throughput, Cost-Effective SNP-Based Platform For Profiling Human Tissue And Cell Lines
February 26, 2015
 · 
4 min read
Load More